Clinic
Dignity Health
Dignity Health was paid $5.61M by Medicaid between Jul 2020 and Dec 2024, across 73 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoDIGNITY HEALTH
GLENDALE, AZ 85308
GLENDALE, AZ 85308
33aNPI1609408665assigned 02/07/2020
33bProvider typeEmergency Care Clinic/Center
28Total paid$5.61M
24GClaims119,369
24DCodes billed73
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Arizona
Rank by total paid#4 of 28
Median peer was paid$2.32M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,764 | $139K | |
| 2021 | 22,114 | $901K | |
| 2022 | 32,361 | $1.49M | |
| 2023 | 35,992 | $1.73M | |
| 2024incomplete | 25,138 | $1.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 12,250 | 11,370 | $1.98M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 8,126 | 7,455 | $1.35M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 17% | 1,813 | 1,708 | $959K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 2,228 | 2,084 | $750K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 2,364 | 2,232 | $182K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 1,092 | 1,039 | $178K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 317 | 296 | $104K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 263 | 247 | $50K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 90 | 85 | $27K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | 15 | $10K |
| 72131 | <1% | 27 | 27 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,187 | 2,824 | $3K |
61 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,981 | $1K |
| 93971 | <1% | 27 | $1K | |
| 73030 | <1% | 72 | $863.04 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 422 | $793.11 |
| 80053 | Comprehensive metabolic panel | <1% | 6,326 | $749.47 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,467 | $740.92 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,258 | $717.93 |
| 81025 | <1% | 3,439 | $564.87 | |
| 93976 | <1% | 218 | $413.09 | |
| 73130 | <1% | 219 | $410.76 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,059 | $358.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,885 | $356.88 |
| 84484 | <1% | 3,148 | $243.62 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 37 | $201.39 |
| 81003 | <1% | 6,544 | $180.22 | |
| 82803 | <1% | 1,947 | $168.17 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 405 | $150.93 |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,191 | $149.71 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 489 | $149.47 |
| 71045 | Radiologic examination, chest; single view | <1% | 3,535 | $146.82 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,703 | $142.84 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,663 | $100.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,394 | $66.44 |
| 83880 | <1% | 611 | $60.30 | |
| 73110 | <1% | 69 | $58.65 | |
| 73610 | <1% | 296 | $58.65 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 697 | $52.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 296 | $51.31 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,411 | $44.15 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,678 | $30.81 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 862 | $26.00 |
| 73630 | <1% | 439 | $24.22 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,100 | $23.83 |
| 83605 | <1% | 1,985 | $18.82 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 83 | $13.09 |
| 80076 | <1% | 1,350 | $12.76 | |
| 80051 | <1% | 2,091 | $12.46 | |
| 82962 | <1% | 219 | $7.23 | |
| 73562 | 0% | 338 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 301 | $0.00 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 12 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,010 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 358 | $0.00 |
| 80305 | 0% | 193 | $0.00 | |
| 90715 | 0% | 85 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 63 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 27 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 12 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 26 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 407 | $0.00 |
| J3490 | Unclassified drugs | 0% | 1,413 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 133 | $0.00 |
| 87040 | 0% | 438 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 775 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 206 | $0.00 |
| 87077 | 0% | 38 | $0.00 | |
| 76801 | 0% | 13 | $0.00 | |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 929 | $0.00 |
| 96376 | 0% | 115 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 32 | $0.00 |
| 83690 | 0% | 57 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKSON, JEFFREY (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
| Provider | Location | Paid |
|---|---|---|
| SJHMC Physician Services | Phoenix, AZ | $46.65M |
| Dignity Health | Litchfield Park, AZ | $4.45M |
| Jackson Pediatric Dentistry of Summerville | Summerville, SC | $443K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.